PAVmed (PAVM) Competitors $0.71 +0.03 (+4.41%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.71 +0.00 (+0.14%) As of 04/17/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. GUTS, TMDIF, APT, ECOR, APYX, TELA, OM, DXR, MODD, and BDMDShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Fractyl Health (GUTS), Titan Medical (TMDIF), Alpha Pro Tech (APT), electroCore (ECOR), Apyx Medical (APYX), TELA Bio (TELA), Outset Medical (OM), Daxor (DXR), Modular Medical (MODD), and Baird Medical Investment (BDMD). These companies are all part of the "medical equipment" industry. PAVmed vs. Fractyl Health Titan Medical Alpha Pro Tech electroCore Apyx Medical TELA Bio Outset Medical Daxor Modular Medical Baird Medical Investment Fractyl Health (NASDAQ:GUTS) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Do analysts prefer GUTS or PAVM? Fractyl Health currently has a consensus target price of $11.00, suggesting a potential upside of 801.64%. PAVmed has a consensus target price of $19.00, suggesting a potential upside of 2,576.06%. Given PAVmed's stronger consensus rating and higher possible upside, analysts plainly believe PAVmed is more favorable than Fractyl Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has preferable valuation and earnings, GUTS or PAVM? PAVmed has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFractyl Health$93K641.75-$77.09M-$1.53-0.80PAVmed$3.00M4.05-$64.18M-$2.25-0.32 Is GUTS or PAVM more profitable? PAVmed has a net margin of 602.97% compared to Fractyl Health's net margin of -64,849.48%. Company Net Margins Return on Equity Return on Assets Fractyl Health-64,849.48% N/A -57.21% PAVmed 602.97%N/A -92.36% Do institutionals and insiders hold more shares of GUTS or PAVM? 19.9% of PAVmed shares are owned by institutional investors. 11.3% of PAVmed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in GUTS or PAVM? PAVmed received 198 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 66.12% of users gave PAVmed an outperform vote. CompanyUnderperformOutperformFractyl HealthOutperform Votes5100.00% Underperform VotesNo VotesPAVmedOutperform Votes20366.12% Underperform Votes10433.88% Does the media refer more to GUTS or PAVM? In the previous week, Fractyl Health had 2 more articles in the media than PAVmed. MarketBeat recorded 3 mentions for Fractyl Health and 1 mentions for PAVmed. Fractyl Health's average media sentiment score of 0.33 beat PAVmed's score of -1.00 indicating that Fractyl Health is being referred to more favorably in the media. Company Overall Sentiment Fractyl Health Neutral PAVmed Negative Which has more risk & volatility, GUTS or PAVM? Fractyl Health has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, PAVmed has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. SummaryPAVmed beats Fractyl Health on 10 of the 18 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.14M$4.07B$5.31B$7.35BDividend YieldN/A46.48%5.45%4.34%P/E Ratio-0.1628.0921.9417.82Price / Sales4.0547.06380.6697.73Price / CashN/A51.0838.2534.64Price / Book-0.215.816.453.98Net Income-$64.18M$67.09M$3.22B$247.81M7 Day Performance-1.42%0.39%0.74%0.28%1 Month Performance-12.35%-11.90%-9.66%-7.60%1 Year Performance-61.83%15.43%11.81%1.49% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed3.7681 of 5 stars$0.71+4.4%$19.00+2,576.1%-61.8%$12.14M$3.00M-0.1690Short Interest ↑Negative NewsGUTSFractyl Health1.7242 of 5 stars$0.99-1.5%$10.00+905.3%-81.4%$48.66M$93,000.00-0.08102Analyst ForecastNews CoverageTMDIFTitan MedicalN/A$0.41-3.1%N/A+793.8%$46.51M$17.63M-0.3350Gap UpAPTAlpha Pro TechN/A$4.25+2.2%N/A-29.6%$46.21M$57.84M11.49120ECORelectroCore3.1889 of 5 stars$5.88+5.6%$25.50+333.7%+6.5%$42.30M$25.18M-3.2150Positive NewsAPYXApyx Medical1.2603 of 5 stars$1.07+11.7%N/A-25.0%$40.44M$48.10M-1.29270News CoverageTELATELA Bio1.9517 of 5 stars$1.01+3.2%$7.25+617.8%-79.9%$39.78M$69.30M-0.60120Short Interest ↑Gap DownOMOutset Medical1.1263 of 5 stars$11.06+8.9%$35.00+216.5%-68.4%$39.76M$113.69M-4.46520High Trading VolumeDXRDaxor4.0238 of 5 stars$7.95-1.2%$25.00+214.5%-24.0%$38.45M$2.13M0.0037Short Interest ↓Gap DownMODDModular Medical0.6965 of 5 stars$0.89+0.6%N/A-45.5%$36.27MN/A-1.6820Short Interest ↑Negative NewsBDMDBaird Medical InvestmentN/A$5.41+7.3%N/AN/A$35.62M$33.05M0.00N/AGap Up Related Companies and Tools Related Companies Fractyl Health Competitors Titan Medical Competitors Alpha Pro Tech Competitors electroCore Competitors Apyx Medical Competitors TELA Bio Competitors Outset Medical Competitors Daxor Competitors Modular Medical Competitors Baird Medical Investment Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAVM Stock Free PAVM Stock Alerts